Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases

Neurosurgical Focus

Volumn 36, Issue 2, 2014, Pages

  Marbacher, Serge ^a,b   Klinger, Elisabeth ^a   Schwyzer, Lucia ^a,b   Fischer, Ingeborg ^a   Nevzati, Edin ^a   Diepers, Michael ^a,b   Roelcke, Ulrich ^a,b   Fathi, Ali Reza ^a,b   Coluccia, Daniel ^a,b   Fandino, Javier ^a,b  

^a Kantonsspital Aarau ^*  (Switzerland)

^b Brain Tumor Center   (Switzerland)

Author keywords

5 ALA; Biopsy; Brain tumor; Fluorescence; Gliolan; Metastasis; protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; FLUORESCENT DYE;

AGED; ARTICLE; BIOPSY; BRAIN TUMOR; FEMALE; HUMAN; MALE; METHODOLOGY; MICROSURGERY; MIDDLE AGED; NEURONAVIGATION; NEUROSURGERY; PATIENT MONITORING; RETROSPECTIVE STUDY;

AGED; AMINOLEVULINIC ACID; BIOPSY; BRAIN NEOPLASMS; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MICROSURGERY; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEURONAVIGATION; NEUROSURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 84894248723     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.12.FOCUS13464     Document Type: Article

References (49)

1. Bekelis K, Valdés PA, Erkmen K, Leblond F, Kim A, Wilson BC, et al: Quantitative and qualitative 5-aminolevulinic acidinduced protoporphyrin IX fluorescence in skull base meningiomas. Neurosurg Focus 30(5):E8, 2011.
2. Colditz MJ, Jeffree RL: Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies. J Clin Neurosci 19:1471-1474, 2012.
3. Colditz MJ, van Leyen K, Jeffree RL: Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects. J Clin Neurosci 19:1611-1616, 2012.
4. Collaud S, Juzeniene A, Moan J, Lange N: On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr Med Chem Anticancer Agents 4:301-316, 2004.
5. Coluccia D, Fandino J, Fujioka M, Cordovi S, Muroi C, Landolt H: Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas. Acta Neurochir (Wien) 152:1711-1719, 2010.
6. Díez Valle R, Tejada Solis S, Idoate Gastearena MA, García de Eulate R, Domínguez Echávarri P, Aristu Mendiroz J: Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102:105-113, 2011.
7. Eicker SO, Floeth FW, Kamp M, Steiger HJ, Hänggi D: The impact of fluorescence guidance on spinal intradural tumour surgery. Eur Spine J 22:1394-1401, 2013.
8. el-Sharabasy MM, el-Waseef AM, Hafez MM, Salim SA: Porphyrin metabolism in some malignant diseases. Br J Cancer 65:409-412, 1992.
9. Eléouet S, Rousset N, Carré J, Bourré L, Vonarx V, Lajat Y, et al: In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem Photobiol 71:447-454, 2000.
10. Ewelt C, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, et al: Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg 113:541-547, 2011.
11. Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N: 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol 82:994-1015, 2006.
12. Frei KA, Bonel HM, Frick H, Walt H, Steiner RA: Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer. Br J Cancer 90:805-809, 2004.
13. Gabeau-Lacet D, Aghi M, Betensky RA, Barker FG, Loeffler JS, Louis DN: Bone involvement predicts poor outcome in atypical meningioma. Clinical article. J Neurosurg 111:464- 471, 2009.
14. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H: 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institution. Swiss Med Wkly 138:180-185, 2008.
15. Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, et al: Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69:260-264, 2007.
16. Idoate MA, Díez Valle R, Echeveste J, Tejada S: Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. Neuropathology 31:575-582, 2011.
17. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K: Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo) 47:53-57, 2007.
18. Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461-469, 1986.
19. Kajimoto Y, Kuroiwa T, Miyatake S, Ichioka T, Miyashita M, Tanaka H, et al: Use of 5-aminolevulinic acid in fluorescenceguided resection of meningioma with high risk of recurrence. Case report. J Neurosurg 106:1070-1074, 2007.
20. Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, et al: 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154:223-228, 2012.
21. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275-292, 1992.
22. Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C: Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13:1339-1348, 2011.
23. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003.
24. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156-162, 2009.
25. Moriuchi S, Yamada K, Dehara M, Teramoto Y, Soda T, Imakita M, et al: Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. J Neurosurg 115:278-280, 2011.
26. Morofuji Y, Matsuo T, Hayashi Y, Suyama K, Nagata I: Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery 62 (3 Suppl 1):102-104, 2008.
27. Muroi C, Fandino J, Coluccia D, Berkmann S, Fathi AR, Landolt H: 5-Aminolevulinic acid fluorescence-guided surgery for spinal meningioma. World Neurosurg 80:223.e1-223.e3, 2012.
28. Ohgari Y, Nakayasu Y, Kitajima S, Sawamoto M, Mori H, Shimokawa O, et al: Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol 71:42-49, 2005.
29. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65:235-251, 1997.
30. Pichlmeier U, Bink A, Schackert G, Stummer W: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10: 1025-1034, 2008.
31. Ritz R, Feigl GC, Schuhmann MU, Ehrhardt A, Danz S, Noell S, et al: Use of 5-ALA fluorescence guided endoscopic biopsy of a deep-seated primary malignant brain tumor. Technical note. J Neurosurg 114:1410-1413, 2011.
32. Roberts DW, Valdés PA, Harris BT, Hartov A, Fan X, Ji S, et al: Glioblastoma multiforme treatment with clinical trials for surgical resection (aminolevulinic acid). Neurosurg Clin N Am 23:371-377, 2012.
33. Sanai N: Emerging operative strategies in neurosurgical oncology. Curr Opin Neurol 25:756-766, 2012.
34. Sanai N, Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753-766, 2008.
35. Sanai N, Snyder LA, Honea NJ, Coons SW, Eschbacher JM, Smith KA, et al: Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. Clinical article. J Neurosurg 115:740-748, 2011.
36. Schucht P, Beck J, Vajtai I, Raabe A: Paradoxical fluorescence after administration of 5-aminolevulinic acid for resection of a cerebral melanoma metastasis. Acta Neurochir (Wien) 153:1497-1499, 2011.
37. Stummer W, Nestler U, Stockhammer F, Krex D, Kern BC, Mehdorn HM, et al: Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol 103:361-370, 2011.
38. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013, 2000.
39. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006.
40. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564-576, 2008.
41. Utsuki S, Miyoshi N, Oka H, Miyajima Y, Shimizu S, Suzuki S, et al: Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study. Brain Tumor Pathol 24:53-55, 2007.
42. Utsuki S, Oka H, Sato S, Suzuki S, Shimizu S, Tanaka S, et al: Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. J Neurosurg 104:618-620, 2006.
43. Valdes PA, Bekelis K, Harris BT, Wilson BC, Leblond F, Kim A, et al: 5-Aminolevulinic-acid-induced protoporphyrin ix fluorescence in meningioma: qualitative and quantitative measurements in vivo. Neurosurgery [epub ahead of print], 2013.
44. Valdés PA, Kim A, Brantsch M, Niu C, Moses ZB, Tosteson TD, et al: δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro Oncol 13:846-856, 2011.
45. Valdés PA, Leblond F, Kim A, Harris BT, Wilson BC, Fan XY, et al: Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. Clinical article. J Neurosurg 115:11-17, 2011.
46. Valdés PA, Moses ZB, Kim A, Belden CJ, Wilson BC, Paulsen KD, et al: Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown. J Neuropathol Exp Neurol 71:806-813, 2012.
47. von Campe G, Moschopulos M, Hefti M: 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies. Acta Neurochir (Wien) 154:585-588, 2012.
48. Widhalm G, Wolfsberger S, Minchev G, Woehrer A, Krssak M, Czech T, et al: 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 116:1545-1552, 2010.
49. Zhao S, Wu J, Wang C, Liu H, Dong X, Shi C, et al: Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-aminolevulinic acid-induced porphyrins: a systematic review and meta-analysis of prospective studies. PLoS ONE 8:e63682, 2013.